How is the Mirum Pharmaceuticals Inc today?

The Mirum Pharmaceuticals Inc today is trading in the green, up by 3.40% at 45.97.

How has Mirum Pharmaceuticals Inc performed historically?

The Mirum Pharmaceuticals Inc is currently trading up 3.40% on an intraday basis in the past week the index rose 4.48%. The index has been down -3.36% in the past quarter and rose 91.30% in the past year. You can view this in the overview section.

What is Mirum Pharmaceuticals Inc Annual Revenue?

Mirum Pharmaceuticals Inc Annual Revenue rose 80.76%, in the last year to $336.89 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Mirum Pharmaceuticals Inc Annual Net Profit?

Mirum Pharmaceuticals Inc Annual Net Profit rose 46.18% in the last year to $87.94 M. Its sector's average net profit growth for the last fiscal year was -12.66%.

What is Mirum Pharmaceuticals Inc Price to Earning Ratio?

Mirum Pharmaceuticals Inc Price to Earning Ratio is -29.44, which is negative.

What is Mirum Pharmaceuticals Inc Stock Price?

Mirum Pharmaceuticals Inc Stock Price rose 91.3% and outperformed its sector by 52.71% in the past year.

What is Mirum Pharmaceuticals Inc Quarterly Revenue?

Mirum Pharmaceuticals Inc Quarterly Revenue rose 61.2% YoY to $111.58 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Mirum Pharmaceuticals Inc Quarterly Net profit?

Mirum Pharmaceuticals Inc Quarterly Net profit rose 41.94% YoY to $14.68 M. Its sector's average net profit growth YoY for the quarter was -235.97%.

What is Mirum Pharmaceuticals Inc Debt to Equity Ratio?

Mirum Pharmaceuticals Inc Debt to Equity Ratio of 1.41 is higher than 1. This implies that company assets are financed through debt.

What is Mirum Pharmaceuticals Inc Return on Equity(ROE)?

Mirum Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -37.08%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Mirum Pharmaceuticals Inc Mutual Fund Holding?

Mirum Pharmaceuticals Inc Mutual Fund Holding decreased by 1.17% in the last quarter to 65.65.

What is Mirum Pharmaceuticals Inc Promoter Share Holding?

Mirum Pharmaceuticals Inc Promoter Share Holding increased by 0.01% in the most recent quarter to 1.29%.

What is Mirum Pharmaceuticals Inc Interest Coverage Ratio?

Mirum Pharmaceuticals Inc Interest Coverage Ratio is -5.07, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Mirum Pharmaceuticals Inc Institutional Holding?

Mirum Pharmaceuticals Inc Institutional Holding increased by 1.17% in the last quarter to 95.19.

Mirum Pharmaceuticals Inc XNAS: MIRM

Mirum Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Mirum Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Mirum Pharmaceuticals Inc
Rating: 1.533402875
Author: Trendlyne DVM scores

Momentum Trap

about

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered,...

45.97 1.51 (3.40%)

91.70% Gain from 52W Low

587.5K XNAS Volume

XNAS 02 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Mirum Pharmaceuticals Inc is on 05 Jun 2025 for the purpose of Mirum Pharmaceuticals Inc Annual General Meeting for 2025 See details

Low Financial Strength

27.8 / 100

Expensive Valuation

10.2 / 100

Technically Neutral

57.0 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 49%

10 analysts

Mirum Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mirum Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered,...

91.70% Gain from 52W Low

SWOT Analysis

Mirum Pharmaceuticals Inc Live Price Chart

Mirum Pharmaceuticals Inc FAQ

How is Mirum Pharmaceuticals Inc today?

Mirum Pharmaceuticals Inc today is trading in the green, and is up by 3.40% at 45.97.

How has Mirum Pharmaceuticals Inc performed historically?

Mirum Pharmaceuticals Inc is currently trading up 3.40% on an intraday basis. In the past week the stock rose 4.48%. stock has been down -3.36% in the past quarter and rose 91.30% in the past year. You can view this in the overview section.